Unveiling Pharmaceutical Deception and Treatment Controversies

This chapter delves into the deceptive marketing strategies of a prominent pharmaceutical company in relation to Neurontin, including a significant lawsuit that revealed misleading information to healthcare professionals. It also examines the controversies surrounding the approval of hydroxychloroquine and ivermectin, highlighting the challenges in pharmaceutical trials and their impact on patient care.